Notice: Function _load_textdomain_just_in_time was called incorrectly. Translation loading for the wordpress-seo domain was triggered too early. This is usually an indicator for some code in the plugin or theme running too early. Translations should be loaded at the init action or later. Please see Debugging in WordPress for more information. (This message was added in version 6.7.0.) in /var/www/html/wp-includes/functions.php on line 6260 2012 Annual Outsourcing Survey | Contract Pharma

What are you searching for?

Sign in
Outsourcing Survey

2012 Annual Outsourcing Survey

Welcome to our 8th Annual Contract Pharma Outsourcing Survey! More than 200 sponsor-side respondents offered up their opinions on outsourcing trends for this year's poll. Here's a breakdown of the respondents, by company type & job function:

By: Gil Roth

President, Pharma & Biopharma Outsourcing Association

Company Type

  • Top 20 Pharma: 23.9%
  • Small/Mid-Tier Pharma: 20.1%
  • Emerging Biopharma: 11.0%
  • Virtual Pharma: 9.6%
  • Generic Pharma: 7.7%
  • Top 10 Biopharma: 6.7%
  • Consumer/OTC Healthcare: 5.3%
  • Specialty Pharma: 2.9%
  • Other: 12.9%

Job Function

  • R&D: 20.6%
  • Corporate Management: 14.4%
  • Project Manager: 10.5%
  • Purchasing/Sourcing: 10.0%
  • Business Development: 7.2%
  • Production/Manufacturing/Packaging: 6.7%
  • QA/QC/Validation: 6.2%
  • Contract Manager: 5.7%
  • Marketing/Sales: 4.8%
  • Clinical Research: 4.8%
  • Supply Chain Manager: 4.3%
  • Regulatory Affairs: 1.9%
  • Other: 2.9%

Plateau?

Last year, 45% of respondents believed that they will spend the same or less on outsourcing spending in the coming year; this year, that rose to 48%. Meanwhile, 49% told us that they spent the same or less on outsourcing in the previous year, down from 51% in our 2011 survey. One-quarter of respondents said that 2011 saw no change in outsourcing spending from 2010.

23% of respondents tell us they had cancelled outsourcing projects in the previous year due to the economy; down from 25% in our 2011 survey. Top 20 Pharma respondents had the highest “cancellation rate” of any company type, at 29%.

Maybe it’s a change in respondents, or maybe it’s an industry trend at last, but 55% of Top 20 Pharma respondents said they use 1-5 preferred vendors, up from 32% in last year’s survey. Top 20 Pharma is still the second lowest group to focus on that number of preferred providers; Generic Pharma was at 54%.

Add us as a preferred source on Google

Get the latest Contract Pharma news, insights and analysis in your Google Search and AI experiences.

Add Contract Pharma as a preferred source on Google (opens in a new tab)

Keep Up With Our Content. Subscribe To Contract Pharma Newsletters

Topics